PMID- 16287152 OWN - NLM STAT- MEDLINE DCOM- 20060119 LR - 20061115 IS - 0008-543X (Print) IS - 0008-543X (Linking) VI - 104 IP - 12 DP - 2005 Dec 15 TI - Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. PG - 2830-6 AB - BACKGROUND: The examination of pancreatic juice cytology could hypothetically contribute to the establishment of a definite diagnosis of malignant intraductal papillary mucinous neoplasm of the pancreas (IPMN), but to the authors' knowledge, its significance has not been confirmed to date. The current study was conducted to assess the diagnostic value of pancreatic juice cytology in IPMN and to examine the usefulness of peroral pancreatoscopy (POPS) in sampling pancreatic juice. METHODS: The study subjects were comprised of 103 patients with IPMN who underwent surgical resection of pancreatic tumors (adenoma in 29 patients, borderline in 17 patients, carcinoma in situ in 25 patients, and invasive carcinoma in 32 patients). Pancreatic juice was collected with a catheter in 71 patients and by POPS in 32 patients. Patients with pancreatic carcinoma (n = 81) and chronic pancreatitis (n = 76) also were investigated. RESULTS: The cytologic diagnosis was found to be of nondiagnostic value in only one patient with an IPMN, whereas it was of no diagnostic value in 14 of the patients with pancreatic carcinoma (17.3%), a difference that was statically significant (P < 0.001). The location of the IPMN (either in the pancreas or the pancreatic ducts) was not found to significantly affect the diagnostic value of the test. The sensitivity for IPMN was 62.2% when pancreatic juice was collected by POPS, and was 38.2% when it was collected using a catheter. In the case of pancreatic carcinoma, the sensitivity of pancreatic juice cytology was found to be 25.4%, which was significantly lower than that for IPMN when the pancreatic juice was collected by POPS (P < 0.001). CONCLUSIONS: Pancreatic juice cytology was found to have better diagnostic value in the patients with IPMNs compared with those with pancreatic carcinoma. POPS was found to be useful for the collection of pancreatic juice. CI - Copyright 2005 American Cancer Society. FAU - Yamaguchi, Taketo AU - Yamaguchi T AD - Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan. yama.take@faculty.chiba-u.jp FAU - Shirai, Yoshihiko AU - Shirai Y FAU - Ishihara, Takeshi AU - Ishihara T FAU - Sudo, Kentarou AU - Sudo K FAU - Nakagawa, Akihiko AU - Nakagawa A FAU - Ito, Hiroshi AU - Ito H FAU - Miyazaki, Masaru AU - Miyazaki M FAU - Nomura, Fumio AU - Nomura F FAU - Saisho, Hiromitsu AU - Saisho H LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Cancer JT - Cancer JID - 0374236 SB - IM MH - Adenocarcinoma, Mucinous/diagnosis/*pathology MH - Adult MH - Aged MH - Aged, 80 and over MH - Carcinoma, Pancreatic Ductal/diagnosis/*pathology MH - Carcinoma, Papillary/diagnosis/*pathology MH - Cholangiopancreatography, Endoscopic Retrograde/methods MH - Cohort Studies MH - Cytodiagnosis/methods MH - Diagnosis, Differential MH - Endoscopy, Digestive System/methods MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Pancreatic Juice/*cytology MH - Pancreatic Neoplasms/diagnosis/*pathology MH - Prognosis MH - Reference Values MH - Retrospective Studies MH - Risk Assessment MH - Sensitivity and Specificity EDAT- 2005/11/16 09:00 MHDA- 2006/01/20 09:00 CRDT- 2005/11/16 09:00 PHST- 2005/11/16 09:00 [pubmed] PHST- 2006/01/20 09:00 [medline] PHST- 2005/11/16 09:00 [entrez] AID - 10.1002/cncr.21565 [doi] PST - ppublish SO - Cancer. 2005 Dec 15;104(12):2830-6. doi: 10.1002/cncr.21565.